Enhancement of cytotoxic effect of epirubicin on gastric carcinoma cell line SGC-7901 by survivin antisense RNA and signaling pathway

HOU Jun; et al

您当前的位置：

首页 >

文章列表页 >

Enhancement of cytotoxic effect of epirubicin on gastric carcinoma cell line SGC-7901 by survivin antisense RNA and signaling pathway

更新时间：2024-01-17

- Enhancement of cytotoxic effect of epirubicin on gastric carcinoma cell line SGC-7901 by survivin antisense RNA and signaling pathway
- Journal of Chongqing Medical University Vol. 34, Issue 5, Pages: 570-574(2009)
- 作者机构：
  
  重庆医科大学附属第一医院普外科
- 作者简介：
- 基金信息：
- DOI：
  CLC： R735.2
- Published：2009，
扫描看全文
[1]侯俊,张才全,彭洪,马国栋.生存素反义寡核苷酸在胃癌化疗中对表阿霉素的增敏性及其信号转导途径研究[J].重庆医科大学学报,2009,34(05):570-574.

HOU Jun, et al. Enhancement of cytotoxic effect of epirubicin on gastric carcinoma cell line SGC-7901 by survivin antisense RNA and signaling pathway. [J]. Journal of Chongqing Medical University 34(5):570-574(2009)
[1]侯俊,张才全,彭洪,马国栋.生存素反义寡核苷酸在胃癌化疗中对表阿霉素的增敏性及其信号转导途径研究[J].重庆医科大学学报,2009,34(05):570-574. DOI：

HOU Jun, et al. Enhancement of cytotoxic effect of epirubicin on gastric carcinoma cell line SGC-7901 by survivin antisense RNA and signaling pathway. [J]. Journal of Chongqing Medical University 34(5):570-574(2009) DOI：

摘要

目的:通过构建survivin反义寡核苷酸

研究其在胃癌化疗中对表阿霉素（Epirubicin

EPI）的增敏作用及作用机制。方法:构建survivin反义寡核苷酸链（Antiscnse RNA

ASODN）及正义寡核苷酸对照链（SODN）

脂质体法转染胃癌SGC-7901细胞

MTT法检测转染组细胞抑制率并筛选出适宜浓度

不同浓度表阿霉素处理胃癌SGC-7901细胞

MTT法检查表阿霉素对其生长抑制作用并筛选出4组浓度做为待测浓度

将2种因素联合作用于SGC-7901细胞

Western-blot法检查survivin蛋白表达情况

MTT法检查表阿霉素对其抑制率

流式细胞仪检查细胞周期

Annexin V-FITC法检查细胞凋亡情况

RT-PCR法检查bcl-2、SMac mRNA表达情况。结果:经200nmol/L survivin反义寡核苷酸处理后的SGC-7901细胞对表阿霉素的敏感性明显增加:MTT法示转染后细胞经表阿霉素作用24h后

抑制率较单独使用表阿霉素的未转染组明显提高（P<0.05

q>1.15）

流式细胞仪检查示联合作用组使细胞G2/M期细胞数较单独使用表阿霉素组明显增多:Western-blot检查示转染后survivin蛋白表达水平显著降低

Annexin V-FITC检查示转染组细胞凋亡明显增加

RT-PCR检查示:SMac mRNA在联合作用组较空白对照组表达上调。结论:Survivin反义寡核苷酸能够增强SGC-7901细胞对表阿霉素的敏感性

其作用可能是通过上调SMac的表达实现的。

Abstract

Objective:To investigate whether interfering survivin has the potential to sensitize stomach cancer cells to Epirubicin.Methods:By the method of liposome transfection

survivin antisense oligodeoxynucleotide was transfected into human stomach cancer SGC-7901 cell line.Treat cells with different concentrations of survivin ASODN and Epirubicin respectively to select the best combination trough assessing the growth of cells by MTT assay.Cells were randomly divided into control group

ASODN group

Epirubicin and combination group.Western blot analysis was used to check the survivin protein expression;inhibitive rate were detected by MTT assay;Flow cytometric analysis was used to detect the cycle status of SGC-7901 cells.The apoptosis was screened according to the result of Annexin V-FITC.Reverse transcription polymerase chain reaction(RT-PCR)were applied to detect the expression of bcl-2、SMac mRNA.Results:MTT assay showed the proliferation of SGC-7901 cells was retarded obviously contrasting to control group.The level of survivin protein expression in ASODN group are lower than control group according to Western blot analysis.Annexin V-FITC show that the apoptosis rate of ASODN group cells increases.The level of SMac mRNA expression in ASODN group are higher than control group according to RT-PCR analysis.Conclusion:Survivin siRNA can sensitize stomach cancer cells to Epirubicin.Up-regulating the SMac expression might be one of mechanisms.

关键词

反义寡核苷酸生存素表阿霉素信号转导途径

Keywords

Antisense RNAsurvivinEpirubicinSignaling pathway

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

PCDH10 prevents multiple myeloma cell escape from epirubicin-induced cytotoxicity

RESULTS OF EPIRUBICIN CONTAINING REGIMENS IN THE MANAGEMENT OF 70 CASES OF MALIGNANT TUMORS

THE DETERMINATION OF EPIRUBICIN AND ITS METABOLITES BY HIGHPERFORMANCE LIQUID CHROMATOGRAPHY

Inhibition of survivin expression by RNA interference in renal cancer cell line 786-O

Related Author

Yang Zesong

Xu Yonghui

Chen Jianbin

Yuan Haiting

白麟祥

时德

Li Huizhi

郑申

Related Institution

Department of Hematology,The First Affiliated Hospital of Chongqing Medical University

重庆医科大学第一医院外科

Department of Urology,the Second Affiliated Hospital,Chongqing Medical University

Department of Respiratory，The First Affiliated Hospital of Chongqing Medical University

Department of Vascular Surgery，The First Affiliated Hospital of Chongqing Medical University

⁰